AMENDED AND RESTATED SHARED SPACE ARRANGEMENTShared Space Arrangement • August 30th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Shared Space Arrangement (this “Shared Space Arrangement”) is made and entered into effective as of the 1st day of September, 2024 (the “Effective Date”) by and between Omega Therapeutics, Inc., a Delaware corporation (“Licensor” or “Tenant”) with an address of 140 First Street, Ste 501, Cambridge, Massachusetts 02141, and Metaphore Biotechnologies, Inc., a Delaware corporation (“Licensee” or “Space Occupant”), with an address of 140 First Street, Ste 502, Cambridge, Massachusetts 02141.
SHARED SPACE ARRANGEMENTShared Space Arrangement • July 13th, 2023 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This shared space arrangement (this “Shared Space Arrangement”) is made and entered into effective as of the 1st day of September, 2023 (the “Effective Date”) by and between Omega Therapeutics, Inc., a Delaware corporation (“Licensor” or “Tenant”) with an address of 140 First Street, Ste 501, Cambridge, Massachusetts 02141, and Apriori Bio, Inc., a Delaware corporation (“Licensee” or “Space Occupant”), with an address as identified on the signature page of this Shared Space Arrangement (the “Signature Page”).
AMENDMENT #1 TO SHARED SPACE ARRANGEMENTShared Space Arrangement • August 6th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances)
This Amendment #1 To Shared Space Arrangement (this “Amendment”) is made effective as of July 1, 2024, by and between OMEGA THERAPEUTICS, INC., a Delaware corporation (“Licensor” or “Tenant”), having an address of 140 First Street, Ste 501, Cambridge, MA 02141, and Metaphore Biotechnologies, Inc., (“Licensee” or “Space Occupant”), having an address of 140 First Street, Ste 502, Cambridge, MA 02141.
AMENDED AND RESTATED SHARED SPACE ARRANGEMENTShared Space Arrangement • November 14th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Amended and Restated Shared Space Arrangement (this “Shared Space Arrangement”) is made and entered into effective as of the 18th day of November, 2024 (the “Effective Date”) by and between Omega Therapeutics, Inc., a Delaware corporation (“Licensor” or “Tenant”) with an address of 140 First Street, Ste 501, Cambridge, Massachusetts 02141, and Prologue Medicines, Inc. (formerly Flagship Labs 89, Inc.), a Delaware corporation (“Licensee” or “Space Occupant”), with an address of 140 First Street, Ste 502, Cambridge, Massachusetts 02141.
SHARED SPACE ARRANGEMENTShared Space Arrangement • August 6th, 2024 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This shared space arrangement (this “Shared Space Arrangement”) is made and entered into effective as of the 1st day of August, 2024 (the “Effective Date”) by and between Omega Therapeutics, Inc., a Delaware corporation (“Licensor” or “Tenant”) with an address of 140 First Street, Ste 501, Cambridge, Massachusetts 02141, and Flagship Labs 97, Inc., a Delaware corporation (“Licensee” or “Space Occupant”), with an address of 55 Cambridge Parkway, Suite 800E, Cambridge, Massachusetts 02142.
SHARED SPACE ARRANGEMENTShared Space Arrangement • July 26th, 2021 • Omega Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This shared space arrangement (this “Shared Space Arrangement”) is made and entered into as of the 13th day of July, 2020 (the “Effective Date”) by and between Kintai Therapeutics, Inc., a Delaware corporation (“Licensor”), and Omega Therapeutics, Inc., a Delaware corporation (“Licensee”), with an address as identified on the signature page of this Shared Space Arrangement (the “Signature Page”).
